The OTC status also applies to generic versions of naloxone 4 mg nasal spray, although, manufacturers of those products have to file for approval to make the switch and update their labelling.

Emergent said in a statement it would make the nasal spray available on store shelves and at online retailers by late summer, but has not yet indicated how much the OTC product will cost.